Literature DB >> 16206071

Increased hepatocyte fas expression and apoptosis in HIV and hepatitis C virus coinfection.

Juan Macias1, Miguel A Japón, Carmen Sáez, Rosa B Palacios, José A Mira, José A García-García, Nicolás Merchante, Salvador Vergara, Fernando Lozano, Jesús Gómez-Mateos, Juan A Pineda.   

Abstract

BACKGROUND: Chronic hepatitis C disease (CHC) follows an accelerated course in human immunodeficiency virus (HIV) coinfection. The reasons for this are unclear. Fas-mediated hepatocyte apoptosis is involved in the pathogenesis of hepatitis C virus (HCV) infection. We sought to compare the expression of Fas on hepatocytes and irreversible apoptosis of hepatocytes among patients with CHC with and without HCV/HIV coinfection.
METHODS: Fas-immunostained hepatocytes were semiquantified, and apoptotic hepatocytes were detected by staining caspase-cleaved cytokeratin 18 filaments and counted across the entire section of liver-biopsy specimens from HCV-infected patients with and without HCV/HIV coinfection.
RESULTS: One hundred thirty-four HCV/HIV-coinfected and 100 HCV-infected patients were included. HCV/HIV coinfection was associated with both diffuse distribution of Fas-stained hepatocytes (adjusted odds ratio [AOR], 7.4 [95% confidence interval {CI}, 3.8-14.4]) and with apoptotic hepatocyte counts greater than the median (AOR, 2.5 [95% CI, 1.5-4.5]). In HCV/HIV-coinfected patients, CD4+ cell nadir<200 cells/mL was associated with both Fas expression (AOR, 2.9 [95% CI, 1.3-6.8]) and hepatocyte apoptosis (AOR, 2.3 [95% CI, 1.1-4.9]).
CONCLUSION: HCV/HIV-coinfected patients show higher levels of hepatocytes expressing Fas and undergoing irreversible apoptosis than do HCV-infected patients. However, low CD4+ cell nadirs in coinfected patients are associated with hepatocyte Fas expression and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16206071     DOI: 10.1086/491736

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

Review 1.  Opioids and HIV/HCV infection.

Authors:  Xu Wang; Ting Zhang; Wen-Zhe Ho
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-14       Impact factor: 4.147

2.  Human immunodeficiency virus infection and the liver.

Authors:  Megan Crane; David Iser; Sharon R Lewin
Journal:  World J Hepatol       Date:  2012-03-27

3.  Lack of short-term increase in serum mediators of fibrogenesis and in non-invasive markers of liver fibrosis in HIV/hepatitis C virus-coinfected patients starting maraviroc-based antiretroviral therapy.

Authors:  J Macías; M M Viloria; A Rivero; I de los Santos; M Márquez; J Portilla; F Di Lello; A Camacho; J Sanz-Sanz; G Ojeda; R Mata; J Gómez-Mateos; J A Pineda
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-01-19       Impact factor: 3.267

Review 4.  HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver?

Authors:  J T Blackard; K E Sherman
Journal:  J Viral Hepat       Date:  2008-01-17       Impact factor: 3.728

Review 5.  Underlying pathophysiology of HCV infection in HIV-positive drug users.

Authors:  Anuradha Balasubramanian; Jerome E Groopman; Ramesh K Ganju
Journal:  J Addict Dis       Date:  2008

Review 6.  Virologic and immunologic aspects of HIV-hepatitis C virus coinfection.

Authors:  Kara W Chew; Debika Bhattacharya
Journal:  AIDS       Date:  2016-10-23       Impact factor: 4.177

Review 7.  Coinfection with HIV-1 and HCV--a one-two punch.

Authors:  Arthur Y Kim; Raymond T Chung
Journal:  Gastroenterology       Date:  2009-06-21       Impact factor: 22.682

8.  TRAIL dependent fratricidal killing of gp120 primed hepatocytes by HCV core expressing hepatocytes.

Authors:  Stacey A Rizza; Kishore B Challagundla; Sekar Natesampillai; Gary D Bren; Jaromir Sykora; Henning Walczak; Andrew D Badley
Journal:  PLoS One       Date:  2011-11-14       Impact factor: 3.240

9.  HAART and the liver: friend or foe?

Authors:  J A Pineda; J Macías; J A Mira; N Merchante; J del Valle; K I Neukam
Journal:  Eur J Med Res       Date:  2010-03-30       Impact factor: 2.175

10.  The case of Scott Ortiz: a clash between criminal justice and public health.

Authors:  Homer D Venters; Asiya M Razvi; Maria S Tobia; Ernest Drucker
Journal:  Harm Reduct J       Date:  2006-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.